EMA — authorised 30 May 2017
- Marketing authorisation holder: BioMarin International Limited
- Status: approved
🇪🇺 Rhttp1 in European Union
EMA authorised Rhttp1 on 30 May 2017
Marketing authorisation
Rhttp1 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Rhttp1 approved in European Union?
Yes. EMA authorised it on 30 May 2017.
Who is the marketing authorisation holder for Rhttp1 in European Union?
BioMarin International Limited holds the EU marketing authorisation.